CATALYST PHARMACEUTICALS INC. - COMMON STOCK
21.48
22-November-24 15:44:58
15 minutes delayed
Stocks
+0.36
+1.70%
Today's range
21.05 - 21.55
ISIN
N/A
Source
NASDAQ
-
Catalyst Pharmaceuticals to Launch LEMS Aware Podcast on Rare Disease Day 2022
17 Feb 2022 07:03:00 By Nasdaq GlobeNewswire
-
07 Feb 2022 07:03:00 By Nasdaq GlobeNewswire
-
03 Feb 2022 07:03:00 By Nasdaq GlobeNewswire
-
10 Jan 2022 07:03:00 By Nasdaq GlobeNewswire
-
Catalyst Pharmaceuticals to Participate in January 2022 Virtual Investor Conferences
04 Jan 2022 06:30:00 By Nasdaq GlobeNewswire
-
06 Dec 2021 06:00:01 By Nasdaq GlobeNewswire
-
15 Nov 2021 15:15:00 By Nasdaq GlobeNewswire
-
Catalyst Pharmaceuticals Reports Third Quarter 2021 Financial Results
09 Nov 2021 15:15:04 By Nasdaq GlobeNewswire
-
Catalyst Pharmaceuticals to Report Third Quarter 2021 Financial Results on November 9, 2021
25 Oct 2021 07:03:00 By Nasdaq GlobeNewswire
-
30 Sep 2021 11:08:12 By Nasdaq GlobeNewswire
-
17 Sep 2021 07:03:00 By Nasdaq GlobeNewswire
-
Catalyst Pharmaceuticals to Participate in Two Upcoming Investor Conferences
10 Sep 2021 07:03:00 By Nasdaq GlobeNewswire
-
Catalyst Pharmaceuticals Appoints Mary Coleman as Vice President, Head of Investor Relations
16 Aug 2021 07:03:00 By Nasdaq GlobeNewswire
-
09 Aug 2021 15:39:16 By Nasdaq GlobeNewswire
-
26 Jul 2021 07:03:00 By Nasdaq GlobeNewswire
-
19 Jul 2021 07:03:00 By Nasdaq GlobeNewswire
-
06 Jul 2021 07:03:00 By Nasdaq GlobeNewswire
-
Catalyst Pharmaceuticals Appoints Pharmaceutical Executive Molly Harper to its Board of Directors
29 Jun 2021 07:03:00 By Nasdaq GlobeNewswire
-
28 Jun 2021 15:30:00 By Nasdaq GlobeNewswire